Remove 2016 Remove Packaging Remove Pharma Companies
article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. This looks like it may change shape in the future for the region, if the proposal put forward by the commission is adopted.

article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. To resolve this discrepancy, pharma sponsors of clinical studies are now actively working towards decentralising trials to make patient participation easier.

Research 130
article thumbnail

Scaling Phage Therapy

Codon

But what is less well-publicized is that the same 2016 review predicted that the vast majority of these deaths – up to 90 percent – will occur in Africa and Asia, where antibiotic use is soaring and access to alternatives is poor. I cover this more extensively in The Good Virus.

Therapies 118